British-Swedish pharmaceutical company AstraZeneca says it will start to book a modest profit from its coronavirus vaccine as it moves away from the nonprofit model it has operated during the pandemic.

British-Swedish pharmaceutical company AstraZeneca says it will start to book a modest profit from its coronavirus vaccine as it moves away from the nonprofit model it has operated during the pandemic.
Tags AstraZeneca
Shares in Australia and Japan fell at the open. US equity-index futures were steady as …
(MENAFN – Asia Times)Two months into US President Donald Trump’s second term, the liberal international …